Related Experiment Video
Updated: Mar 8, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
RAP1B, a DVL2 binding protein, activates Wnt/beta-catenin signaling in esophageal squamous cell carcinoma
Zhao Jia1, Yang Yang1, Zhu Dengyan1
1Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Henan province, PR China; Department of Key Thoracic Tumour Experimental Laboratory of Zhengzhou, PR China.
Abstract:
RAP1B is a small GTPase, which regulates multiple cellular processes. Up-regulation of RAP1B has been observed in several cancer types. Although previous study has shown that miR-518 inhibited the proliferation and invasion of esophageal squamous cell carcinoma (ESCC) cells possibly by targeting RAP1B, the expression pattern and the functions of RAP1B in ESCC are not fully understood. Here, we have fund that the expression of RAP1B was up-regulated in ESCC clinical samples. Gain-of-function and loss-of-function assays demonstrated that RAP1B promoted the growth, migration and metastasis of the ESCC cells. Moreover, the mechanism study showed that RAP1B interacted with DVL2, an important upstream regulator for beta-catenin/TCF signaling, and activated beta-catenin/TCF signaling. Taken together, our study demonstrated the oncogenic roles of RAP1B in ESCC, and suggested that RAP1B might be a therapeutic target.
Insights
RAP1B protein promotes esophageal squamous cell carcinoma (ESCC) growth and metastasis. Targeting RAP1B may offer a new therapeutic strategy for ESCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- RAP1B, a small GTPase, is implicated in various cellular functions and upregulated in cancers.
- Previous research suggests miR-518 targets RAP1B in esophageal squamous cell carcinoma (ESCC), but RAP1B's role in ESCC requires further elucidation.
Purpose of the Study:
- To investigate the expression pattern and functional significance of RAP1B in esophageal squamous cell carcinoma (ESCC).
- To explore the underlying molecular mechanisms by which RAP1B influences ESCC progression.
Main Methods:
- Analysis of RAP1B expression in ESCC clinical samples.
- In vitro gain-of-function and loss-of-function assays to assess RAP1B's impact on ESCC cell behavior.
- Mechanistic studies involving protein-protein interactions and signaling pathway analysis.
Main Results:
- RAP1B expression is significantly upregulated in ESCC tissues.
- Elevated RAP1B expression enhances ESCC cell proliferation, migration, and metastasis.
- RAP1B interacts with DVL2, activating the beta-catenin/TCF signaling pathway.
Conclusions:
- RAP1B plays a crucial oncogenic role in the development and progression of ESCC.
- RAP1B's activation of the beta-catenin/TCF pathway contributes to its pro-tumorigenic effects.
- RAP1B represents a potential therapeutic target for esophageal squamous cell carcinoma.
Related Concept Videos
Canonical Wnt Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Non-Canonical Wnt Signaling Pathways
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

